CCM
IMUX icon

Connective Capital Management’s Immunic IMUX Stock Holding History

Connective Capital Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,130
Closed -$161K – 73
2025
Q4 		$161K Buy
+30,130
New +$221K 0.09% 44
2024
Q1 		– Sell
-32,870
Closed -$493K – 55
2023
Q4 		$493K Buy
+32,870
New +$403K 0.41% 41

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Connective Capital Management's IMUX Position: Q1 2026 in Review

Connective Capital Management sold out of Immunic (IMUX) in Q1 2026, closing a stake of 30,130 shares — an estimated $161K sold.

Connective Capital Management first reported a position in IMUX in Q4 2023 and held it in 2 quarters. The position peaked at $493K in Q4 2023. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Connective Capital Management reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • Connective Capital Management sold 30,130 Immunic shares in Q1 2026, an estimated $161K.
  • Connective Capital Management first reported a position in Immunic in Q4 2023 and held it in 2 quarters.
  • Connective Capital Management's Immunic position peaked at $493K in Q4 2023.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Connective Capital Management's 13F filing for Q1 2026, filed 13 May 2026.